Dicarboxylate Containing
Dicarboxylate Containing - Related Videos
07:25
Green and Low-cost Production of Thermally Stable and Carboxylated Cellulose Nanocrystals and Nanofibrils Using Highly Recyclable Dicarboxylic Acids
0 Views •
Cited by 22 •
2017
Here we demonstrate a novel method for green and sustainable productions of highly thermally stable and carboxylated cellulose nanocrystals (CNC) and nanofibrils (CNF) using highly recyclable solid dicarboxylic acids.
01:13
Intramolecular Claisen Condensation of Dicarboxylic Esters: Dieckmann Cyclization
0 Views •
2023
Dieckmann cyclization is an intramolecular Claisen condensation of diesters. The reaction occurs in the presence of a base and generates a cyclic β-ketoester as the final product. Commonly, 1, 6 and 1, 7-diesters are preferred substrates for the reaction since the generated five, and six-membered cyclic β-keto esters are particularly more stable. In the reaction, α carbon connected to one end of the ester ends serves as an enolate nucleophile after losing its proton to the base. The carbonyl...
06:45
Polymerization
0 Views •
2023
Source: Vy M. Dong and Jan Riedel, Department of Chemistry, University of California, Irvine, CA Polymers are made from macromolecules, which are composed of repeating units (the so called monomeric units). In our modern world, polymers play an important role. One of the first important polymers was nylon, which is a polyamide. It found widespread application in tooth brushes and stockings.
FAQs
Ionization can increase polarity and introduce negative charge, which strengthens ionic and hydrogen-bonding interactions but may reduce membrane permeability. The balance between charged and less-charged forms therefore influences whether a compound remains soluble in aqueous environments, crosses biological membranes, reaches tissues, or is eliminated. Modifying ionization is consequently an important strategy in pharmacological design.
The charged groups provide sites for ionic and hydrogen-bonding interactions with proteins, while also enabling interactions with metal ions. These contacts can influence how strongly a compound associates with a drug target or transport system. Their effects are not limited to target binding, because the same chemical features can alter solubility, distribution, and elimination.
A more ionized compound generally has greater polarity and stronger aqueous compatibility, whereas a less-ionized form may have improved membrane passage. This creates a pharmacological tradeoff between solubility and tissue delivery. Comparing these forms helps researchers determine whether a compound’s limiting property is aqueous behavior, membrane permeability, target interaction, or a combination of these factors.
Ionization can be deliberately modified to balance the properties needed for pharmacological use. Increasing compatibility with aqueous biological environments may support solubility, while reducing the effect of negative charge may help membrane passage. Such adjustments are evaluated because changes in ionization can influence target binding, transport, distribution, and elimination at the same time.
Evaluation should connect chemical behavior with pharmacological consequences. Key considerations include ionization in aqueous biological environments, polarity, ionic and hydrogen-bonding interactions, solubility, membrane permeability, distribution, elimination, and binding to proteins, metal ions, or transport systems. Examining these properties together helps explain why a candidate may show useful target interactions yet limited tissue delivery.
A prodrug approach is relevant when the parent compound has chemical features that restrict absorption or tissue delivery, particularly because of its ionization and polarity. Temporarily changing how those features affect biological transport can improve access to the desired site. Researchers then consider whether the strategy better balances absorption, distribution, and pharmacological activity than the original compound.
Their ionization and polarity affect how they behave in aqueous biological environments and how readily they interact with transport systems. Those factors can shape movement between tissues and the processes that remove the compound from the body. Consequently, distribution and elimination must be interpreted alongside solubility, membrane permeability, and protein or metal-ion interactions rather than as isolated properties.
Dicarboxylate chemistry links molecular structure to several outcomes that determine therapeutic potential. The relevant features can affect target binding, transport, solubility, membrane passage, tissue delivery, distribution, and elimination. In pharmacology, this framework supports both direct evaluation of candidate molecules and design decisions that modify ionization or use prodrugs to address limitations in absorption or delivery.